Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Completed 4Recruiting 2

Sponsor Class

OTHER 2

Study Type

Observational 1Interventional 1

Sponsor

Cancer Type

Gastrointestinal 2

Conditions

Colorectal Neoplasms 6Cholangiocarcinoma 4Carcinoma, Hepatocellular 4Recurrence 2Klatskin Tumor 2Fibrosis 2Reperfusion Injury 1Liver Neoplasms 1Liver Diseases 1Hypertension, Portal 1Colorectal Cancer Metastatic 1Bile Duct Neoplasms 1

Interventions

Cyclophosphamide 21venetoclax 18pembrolizumab 16Dexamethasone 16fludarabine 14Cytarabine 13Gemcitabine 9pomalidomide 8Rituximab 8Carboplatin 8Azacitidine 8glofitamab 7fludarabine phosphate 7Lenalidomide 7Immunotherapy, Adoptive 7selinexor 6Paclitaxel 6Injections 6Granulocyte Colony-Stimulating Factor 6Cisplatin 6daratumumab 5Temozolomide 5Oxaliplatin 5Bevacizumab 5zanubrutinib 4ruxolitinib 4Surgical Procedures, Operative 4Nivolumab 4Drug Therapy 4Decitabine 4

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Recruiting × Recurrence × Liver Transplantation × Clear all
NCT05276037 2022-09-01

Value of Negative 18FDG PET/CT in Milan Out, Up-to-seven in, HCC Transplant Candidates

University of Liege

Recruiting
350 enrolled
Gastrointestinal

Carcinoma, Hepatocellular, Recurrence

NCT04499833 2022-06-06

HepatoPredict

Centro Hospitalar de Lisboa Central

Phase NA Recruiting
40 enrolled
Gastrointestinal

Fibrosis, Carcinoma, Hepatocellular, Recurrence

Data powered by HemOnc (CC BY 4.0) Colophon âš¡